Voltar
Artigo Acesso aberto Revisado por pares
BIBTEX RIS

Efficacy and activity of treatments after progression from palbociclib plus endocrine therapy in patients with HR+/HER2– metastatic breast cancer: a prospective, monocentric study

2023; BioExcel Publishing Ltd; Volume: 13; Linguagem: Inglês

10.7573/dic.2023-7-5

ISSN

1745-1981

Autores

Raffaella Palumbo, Erica Quaquarini, Giuseppe Saltalamacchia, Alberto Malovini, Pietro Lapidari, Barbara Tagliaferri, Luca Mollica, Cristina Teragni, Chiara Barletta, Laura D. Locati, Federico Sottotetti,

Tópico(s)

Chronic Lymphocytic Leukemia Research

Resumo

Breast cancer is the most frequent tumour worldwide, and the HR

Referência(s)